In a report released today, Justin Smith from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF345.00. The company’s shares closed ...

In a report released today, James Quigley from Goldman Sachs maintained a Sell rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF274.00. The company’s shares ...

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Roche Holding AG Akt 1.04% CHF232.83B ...

If Canada were to become part of America, some changes would be in order. American history has seen the country grow in size and Betsy Ross’ flag grow in stars but Trump’s ideas ebb between ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Roche Holding AG Akt-0.45% CHF234.65B ...

U.S. President Donald Trump, right, and Justin Trudeau, Canada's prime minister, arrive to a news conference in the East Room of the White House in Washington, D.C., U.S., on Monday, Feb. 13, 2017 ...

Power Metals Corp ("Power Metals" or the "Company") (TSX VENTURE: PWM) (FRANKFURT: OAA1) (OTCQB: PWRMF) is pleased to ...